Efficacy of Coenzyme Q10 Supplementation on Metabolic Control in Children With Type 1 Diabetes Mellitus: a Randomized Clinical Trial

Trial ID: NCT06361680

Interventional - Phase 1 - Unknown status

Determine the effect of Coenzyme Q10 on random blood sugar and glycosylated haemoglobin

Conditions

• Type 1 Diabetes Mellitus

Interventions

• Coenzyme Q10 Cap/Tab as natural factors capsules or kirkman tablets

Eligibility

Inclusion criteria

• All patients diagnosed as type 1 diabetes mellitus from age of 2 years old to 18 years old with diabetes mellitus of duration at least 1 year.

Exclusion criteria

• \- patients diagnosed as diabetes mellitus less than 2 years old .
• patients with diabetes mellitus of duration less than 1 year.
• patients diagnosed as type 1 diabetes mellitus with Thyroid or celiac diseases.
• other types of hyperglycemia rather than Type 1 diabetes mellitus.

Sponsor

Assiut University

Source: ClinicalTrials.gov

Search more clinical trials on myTomorrows